Description

What’s molnupiravir?

Molnupiravir is an oral antiviral drug developed for the treatment of COVID-19. It does this by introducing errors into the genetic material of SARS-CoV-2, and this can impair the virus’ ability to replicate.

But medical evidence and official recommendations can change, and treatment options with it. Patients should always seek the advice of a qualified healthcare professional regarding their COVID-19 treatment options.

#### What is molnupiravir used for?

Molnupiravir has been given to some adults with mild-to-moderate COVID-19 who are at increased risk for severe disease. In the US, the FDA information has described use when other COVID-19 treatment options are unavailable or clinically inappropriate.

Early treatment initiation is also recommended. Molnupiravir is listed as an alternative option for adults in CDC guidance when preferred treatments are not feasible or available.

How Molnupiravir Works

This is different from drugs that directly block a specific viral protein. Instead molnupiravir causes copying errors when the virus replicates its genetic material. So the virus may have a harder time making working copies of itself.

This medicine is not a substitute for vaccination and general measures to reduce the risk of COVID-19.

Important Safety Information

Do not take molnupiravir without professional medical advice. Healthcare professionals take into account age, symptoms, risk of severe disease, pregnancy status and other treatment options available.

Molnupiravir is also not recommended in pregnancy due to the potential risk to the developing foetus. The CDC guidance also advises against it during pregnancy and mentions contraception considerations for people who can become pregnant and their partners.

Molnupiravir is also not approved for children due to concerns about bone and cartilage growth.

When to see a doctor

If you test positive for COVID-19 and have risk factors for severe illness, contact a health care professional right away. Early assessment is important as antiviral treatments are most effective if started within the correct treatment window.

If you develop serious symptoms such as trouble breathing, chest pain that does not go away, confusion or other signs of serious illness, seek immediate medical attention.

Frequently asked questions.

Molnupiravir is not an antibiotic.

“No. Molnupiravir is an antiviral medicine, which means it works to stop viral replication, not bacterial infections.

Can every person with COVID-19 take molnupiravir?

“No. It is contingent upon the patient’s circumstances and the alternative treatment options available and whether a health professional thinks it is appropriate.

Molnupiravir: Is it a replacement for vaccination?

“No. Vaccination and antiviral treatment are used for different reasons. Hence, patients should follow the existing vaccination and treatment guidelines of licensed healthcare providers.

Why Treat Early?

COVID-19 antivirals are generally most effective when started within the recommended treatment window. “So if you are at higher risk, you should seek medical attention soon after symptoms or a positive test.

Conclusion

Molnupiravir is an oral antiviral medicine used in the treatment of some higher-risk adults with COVID-19. However, it is not suitable for everyone, and other treatments may be preferred where available and clinically appropriate. Therefore, before using this medicine, patients should consult a qualified healthcare professional.